TR Activebeta US Small Cap Equity ETF (GSSC)
| Assets | $737.16M |
| Expense Ratio | 0.20% |
| PE Ratio | 16.16 |
| Shares Out | 9.55M |
| Dividend (ttm) | $1.08 |
| Dividend Yield | 1.41% |
| Ex-Dividend Date | Sep 24, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 22.58% |
| Volume | 27,189 |
| Open | 77.23 |
| Previous Close | 77.14 |
| Day's Range | 76.30 - 77.80 |
| 52-Week Low | 54.91 |
| 52-Week High | 78.74 |
| Beta | 1.04 |
| Holdings | 1330 |
| Inception Date | Jun 28, 2017 |
About GSSC
Fund Home PageThe TR Activebeta US Small Cap Equity ETF (GSSC) is an exchange-traded fund that mostly invests in small-cap stocks. The fund tracks a tier-weighted index of US small-cap stocks. The index equally weights four factor-based sub-indices: value, momentum, quality, and low volatility GSSC was launched on Jun 28, 2017 and is issued by Goldman Sachs.
Top 10 Holdings
5.49% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Sachs FS Treasury Obligs Instl | FTOXX | 1.40% |
| E-mini Russell 2000 Index Future Mar 26 | n/a | 1.36% |
| IES Holdings, Inc. | IESC | 0.46% |
| Credo Technology Group Holding Ltd | CRDO | 0.42% |
| Enova International, Inc. | ENVA | 0.36% |
| Fabrinet | FN | 0.31% |
| Watts Water Technologies, Inc. | WTS | 0.31% |
| PTC Therapeutics, Inc. | PTCT | 0.30% |
| Alkermes plc | ALKS | 0.29% |
| ACADIA Pharmaceuticals Inc. | ACAD | 0.29% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 24, 2025 | $0.27121 | Sep 30, 2025 |
| Jun 24, 2025 | $0.19429 | Jun 30, 2025 |
| Mar 25, 2025 | $0.17552 | Mar 31, 2025 |
| Dec 23, 2024 | $0.4371 | Dec 30, 2024 |
| Sep 24, 2024 | $0.11644 | Sep 30, 2024 |
| Jun 24, 2024 | $0.23008 | Jun 28, 2024 |
Performance
GSSC had a total return of 5.37% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.21%.
News
GSSC: Mid-Tier Small-Cap ETF Beating The Russell 2000 Index
GSSC is benchmarked against the Russell 2000 Index and aims to provide more exposure to the value, momentum, quality, and low volatility factors. Its expense ratio is low at 0.20%. My fundamental anal...
Why Is The IPO Market Struggling? Here's What Active Managers Have To Say
Strong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of companies going public via the IPO process — as well as the potential impl...